Wall Street Zen upgraded shares of VSee Health (NASDAQ:VSEE – Free Report) to a sell rating in a research note published on Saturday morning.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of VSee Health in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $5.00.
Read Our Latest Stock Analysis on VSEE
VSee Health Stock Performance
VSee Health (NASDAQ:VSEE – Get Free Report) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.06. VSee Health had a negative net margin of 69.80% and a negative return on equity of 131.02%. The firm had revenue of $3.98 million for the quarter, compared to analysts’ expectations of $4.10 million.
Institutional Investors Weigh In On VSee Health
Large investors have recently added to or reduced their stakes in the company. XTX Topco Ltd purchased a new stake in VSee Health during the 1st quarter worth $34,000. Osaic Holdings Inc. grew its stake in shares of VSee Health by 197.5% during the second quarter. Osaic Holdings Inc. now owns 45,170 shares of the company’s stock valued at $52,000 after acquiring an additional 29,985 shares in the last quarter. Finally, HB Wealth Management LLC purchased a new stake in shares of VSee Health during the third quarter worth about $368,000. 1.01% of the stock is owned by institutional investors and hedge funds.
About VSee Health
VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.
Featured Articles
- Five stocks we like better than VSee Health
- 3 Monster Growth Stocks to Buy Now
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- How to Calculate Stock Profit
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
- What Are Dividend Contenders? Investing in Dividend Contenders
- MarketBeat Week in Review – 12/1 – 12/5
Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.
